CCR5 antagonists as therapeutic agents
US7645771B2 · kind B2 · utility
12Cited by
7References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 12, 2003 |
| Grant date | Jan 12, 2010 |
| Priority date | — |
| Expiry date | Nov 16, 2025 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P31/18
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to compounds of formula (I) or a pharmaceutically acceptable derivatives thereof, useful in the treatment of prophylazis of CCR5-related diseases and disorders, for example, in the inhibition of HIV replication, the prevention or treatment of HIV infection, and in the treatment of the resulting acquired immune deficiency syndrome (AIDS).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.